Loading...

GlucoTrack, Inc.

IGAP•NASDAQ
Healthcare
Medical - Instruments & Supplies
$3.24
$0.09(2.86%)

GlucoTrack, Inc. (IGAP) Stock Overview

Explore GlucoTrack, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.2/100

Key Financials

Market Cap50.2M
P/E Ratio-0.21
EPS (TTM)$-0.31
ROE3.93%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.29

IGAP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GlucoTrack, Inc. (IGAP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.21 and a market capitalization of 50.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;